Alloway Advised FDA at Public Hearing
On June 21, Rita Alloway, PharmD, research professor in the division of nephrology and hypertension, participated in a Food and Drug Administration public hearing, "Generic Drug User Fee Amendments of 2012 Regulatory Science initiatives: Request for Public Input for FY 2014 Generic Drug Research The Food and Drug Administration.
Alloway represented the American Society of Transplantation to advise the FDA related to future research efforts in generic drug use in transplantation. In addition to reviewing the status of the currently FDA funded U01, she provided specific study recommendations for future studies.
Tags
Related Stories
UC students organize free health clinic happening July 11-12
July 10, 2026
The University of Cincinnati student chapter of Remote Area Medical is holding its annual free health clinic July 11-12. The clinic is open to adults and children, with no income requirements. Anyone in the area who needs medical, dental or vision care will have a chance to get it for free, with no insurance required.
Is speech-to-text AI really reliable?
July 10, 2026
UC researcher Nelly Elsayed’s study in the International Journal of Medical Informatics reveals key risks in clinical speech-to-text AI and shows why human review is essential.
Hoxworth Blood Center CEO advocates on Capitol Hill during National Blood Advocacy Week
July 9, 2026
Hoxworth Blood Center, University of Cincinnati, has announced that David Oh, MD, director and chief executive officer, joined blood center leaders, patient advocates and partner organizations in Washington, D.C., in June as part of Blood Advocacy Week, a national initiative led by America’s Blood Centers to strengthen the nation’s blood supply.